Pro-Dex Inc (NASDAQ:PDEX) CFO Alisha Charlton sold 2,114 shares of the stock in a transaction dated Wednesday, February 13th. The stock was sold at an average price of $15.81, for a total transaction of $33,422.34. Following the sale, the chief financial officer now owns 4,778 shares in the company, valued at $75,540.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Pro-Dex stock traded down $0.85 during trading hours on Wednesday, reaching $15.15. 47,700 shares of the stock were exchanged, compared to its average volume of 35,153. The company has a market capitalization of $62.93 million, a price-to-earnings ratio of 28.68 and a beta of 0.86. The company has a quick ratio of 6.08, a current ratio of 7.78 and a debt-to-equity ratio of 0.25. Pro-Dex Inc has a twelve month low of $6.05 and a twelve month high of $16.15.
Several institutional investors and hedge funds have recently bought and sold shares of the company. Alambic Investment Management L.P. acquired a new stake in shares of Pro-Dex in the 4th quarter valued at approximately $837,000. EAM Investors LLC acquired a new stake in shares of Pro-Dex in the 3rd quarter valued at approximately $664,000. Vanguard Group Inc boosted its stake in shares of Pro-Dex by 50.8% in the 3rd quarter. Vanguard Group Inc now owns 49,399 shares of the medical instruments supplier’s stock valued at $514,000 after purchasing an additional 16,644 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Pro-Dex by 50.8% in the 3rd quarter. Vanguard Group Inc. now owns 49,399 shares of the medical instruments supplier’s stock valued at $514,000 after purchasing an additional 16,644 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its stake in shares of Pro-Dex by 42.6% in the 4th quarter. Acadian Asset Management LLC now owns 41,313 shares of the medical instruments supplier’s stock valued at $499,000 after purchasing an additional 12,337 shares in the last quarter. Institutional investors own 7.81% of the company’s stock.
WARNING: This piece of content was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.com-unik.info/2019/02/13/insider-selling-pro-dex-inc-pdex-cfo-sells-2114-shares-of-stock.html.
Pro-Dex, Inc, together with its subsidiaries, designs, develops, and manufactures powered surgical instruments, dental instruments, and rotary air motors worldwide. It also manufactures plastic injection molds for various industries; and shavers and machined parts. In addition, it provides engineering, and quality and regulatory consulting services.
Featured Story: Ex-Dividend
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.